Your browser doesn't support javascript.
loading
NK cell dynamics and association with molecular response in early chronic phase chronic myelogenous leukemia (CML-CP) patients treated with nilotinib.
Sopper, S; Mustjoki, S; Gjertsen, B T; Giles, F; Hochhaus, A; Janssen, J J W M; Porkka, K; Wolf, D.
Afiliação
  • Sopper S; Department of Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria.
  • Mustjoki S; Tyrolean Cancer Research Institute, Innsbruck, Austria.
  • Gjertsen BT; Hematology Research Unit Helsinki, University of Helsinki and Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Giles F; Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland.
  • Hochhaus A; Institute of Medicine, Hematology Section, University of Bergen, Bergen, Norway.
  • Janssen JJWM; NMDTI, Northwestern University, Chicago, USA.
  • Porkka K; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany.
  • Wolf D; Department of Hematology, VU University Medical Center, Amsterdam, Netherlands.
Leukemia ; 31(10): 2264-2267, 2017 10.
Article em En | MEDLINE | ID: mdl-28744011
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Células Matadoras Naturais / Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide de Fase Crônica / Antineoplásicos Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Células Matadoras Naturais / Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide de Fase Crônica / Antineoplásicos Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article